BCL2L1 and nasopharyngeal carcinoma: NGN has a specific inhibitory effect on the metabolic activities of NPC cells, particularly in suppressing oncogenic KRAS−PI3K−Rac1−Akt−BCL-2/BCL-xL signaling pathways by attenuating MCPIP1-mediated pre-let-7g degradation.